总体新辅助疗法后的监测:对于近完全响应者,应该做些什么?
1Las Vegas Complex Surgical Specialists, Las Vegas, Nevada.
Clinics in colon and rectal surgery
|June 17, 2024
概括
患有直肠癌的患者在全新辅助疗法后获得近乎完整的反应,面临着争论的管理策略. 本综述探讨了治疗选择,监测和最佳患者护理的结果.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 手术瘤学手术瘤学
背景情况:
- 全新辅助疗法 (TNT) 越来越多地用于直肠癌.
- 一部分患者在TNT后实现了近完全反应 (nCR).
- 对nCR直肠癌患者的最佳管理仍然存在争议.
研究的目的:
- 审查对直肠癌患者的治疗策略,这些患者在TNT后患有nCR.
- 检查这个患者群体的监测选择.
- 综合相关的结果数据,以提供知情决策.
主要方法:
- 对TNT后直肠癌管理研究的文献综述.
- 对治疗干预和监测协议的分析.
- 评估临床结果,包括复发率和生存率.
主要成果:
- 目前对nCR直肠癌的治疗方法的异质性.
- 有限的高质量数据比较不同的TNT后策略.
- 关于观察和等待对手术切除的安全性和有效性的新兴证据.
结论:
- 个性化治疗计划对于TNT后nCR的直肠癌患者至关重要.
- 需要进一步的研究来建立标准化指南.
- 将癌症结果与生活质量之间的平衡至关重要.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...